BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/10/2016 8:16:00 AM | Browse: 1010 | Download: 961
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 23899
Country/Territory United States
Received
2015-12-23 08:37
Peer-Review Started
2015-12-24 08:02
To Make the First Decision
2016-01-18 11:51
Return for Revision
2016-01-21 17:35
Revised
2016-01-27 05:24
Second Decision
2016-03-07 15:24
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-03-16 15:58
Articles in Press
2016-03-16 15:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-04-25 11:31
Publish the Manuscript Online
2016-05-10 08:16
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines
Manuscript Source Invited Manuscript
All Author List Barry M Berger, Bernard Levin and Robert J Hilsden
Funding Agency and Grant Number
Corresponding Author Barry M Berger, MD, Chief Medical Officer, Medical Affairs, Exact Sciences Corporation, 5801 Research Park Blvd, Madison, WI 53719, United States. bberger@exactsciences.com
Key Words Colorectal cancer screening; Multitarget stool DNA; Stool DNA; The United States Preventive Services Task Force; Cancer Intervention Surveillance Modeling Network; Fecal immunological technique; Modeling; Interval
Core Tip Multi-target stool DNA (mt-sDNA) testing was approved for average risk colorectal cancer (CRC) screening by the United States Food and Drug Admini-stration (2014). The evidence supporting mt-sDNA for routine screening use is robust. The clinical efficacy of mt-sDNA every three years, measured by life-years gained, and CRC deaths averted, is similar to that of other screening strategies more specifically recommended by the United States Preventive Services Task Force. In an irregularly screened population, however, tests with the highest point sensitivity and reasonable specificity like mt-sDNA are more likely to reduce CRC related morbidity and mortality than less sensitive tests that depend on annual adherence to achieve high programmatic sensitivity.
Publish Date 2016-05-10 08:16
Citation Berger BM, Levin B, Hilsden RJ. Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines. World J Gastrointest Oncol 2016; 8(5): 450-458
URL http://www.wjgnet.com/1948-5204/full/v8/i5/450.htm
DOI http://dx.doi.org/10.4251/wjgo.v8.i5.450
Full Article (PDF) WJGO-8-450.pdf
Full Article (Word) WJGO-8-450.doc
Manuscript File 23899-Review.docx
Answering Reviewers 23899-Answering reviewers.pdf
Audio Core Tip 23899-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 23899-Conflict-of-interest statement.pdf
Copyright License Agreement 23899-Copyright assignment.pdf
Peer-review Report 23899-Peer-review(s).pdf
Scientific Misconduct Check 23899-Scientific misconduct check.pdf
Scientific Editor Work List 23899-Scientific editor work list.pdf